STERIS plc
STEHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeSTERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company carries a $21.23B market cap, placing it firmly in the large-cap category. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.
Market Cap
$21.23B
Beta
0.92
P/E (TTM)
27.86
P/E (Fwd)
17.89
EPS (TTM)
$7.82
EPS (Fwd)
$12.18
ROE
11.4%
ROA
6.7%
Cash
$439.6M
Total Debt
$2.09B
Free CF
$837.3M
52W Change
-3.4%
Annual Financials
Cash vs Debt
On the balance sheet, STE has $439.6M in cash with $2.09B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $837.3M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 11.4% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 6.7% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $4.54B (2023) to $5.94B (2026), reflecting a 31% increase over the period.
Investors considering STERIS plc should weigh the typical risks associated with STE's sector, size, and financial profile against their own risk tolerance and investment objectives. No single metric tells the full story. Reviewing STE's risk profile alongside its fundamentals and technical indicators provides a more complete picture.